Disclosure Panels Details Page
Chronic Myeloid Leukemia Panel - Disclosures as of 05/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Jessica Altman MD | AbbVie, Inc. ALX Oncology Amgen Inc. Aprea Aptos Astellas Pharma US, Inc. BioSight Bristol-Myers Squibb Company Cellectis Fujifilm Corporation Gilead Sciences, Inc. GlycoMimetics, Inc. ImmunoGen, Inc. Kartos Kura Oncology, Inc. MEI Pharma Inc. Rafael Telios |
Astellas Pharma US, Inc. BlueBird Bio Curio Daiichi- Sankyo Co. Gilead Sciences, Inc. Kura Oncology, Inc. Kymera Stemline Syros Pharmaceuticals |
GlycoMimetics, Inc. | None | 03/30/2023 |
| Maria Amaya PhD,MD | None | None | None | None | 03/15/2023 |
| Kebede Begna MD | None | Novartis Pharmaceuticals Corporation | None | None | 02/07/2023 |
| Ellin Berman MD | Novartis Pharmaceuticals Corporation Takeda Pharmaceuticals North America, Inc. |
Novartis Pharmaceuticals Corporation | None | None | 03/14/2023 |
| Ravi Bhatia MD | None | None | None | None | 12/13/2022 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Robert Collins MD | None | Ro5 Inc. | None | None | 03/21/2023 |
| Peter Curtin MD | CRISPR Therapeutics | None | None | None | 03/13/2023 |
| Daniel DeAngelo PhD,MD | AbbVie, Inc. Blueprint Medicines Daiichi- Sankyo Co. GlycoMimetics, Inc. Mt Sinai MPN Consortium Novartis Pharmaceuticals Corporation |
None | Amgen Inc. Autolus Blueprint Medicines Jazz Pharmaceuticals Inc. Kite Pharma Novartis Pharmaceuticals Corporation Pfizer Inc. Servier Takeda Pharmaceuticals North America, Inc. |
None | 05/23/2023 |
| Sarah DeVincenzo BCPS,PharmD | None | None | None | None | 05/22/2023 |
| Tanya Fischer MLIS,MEd | None | None | None | None | 05/24/2023 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 04/28/2023 |
| Erin Hesler | None | None | None | None | 04/04/2023 |
| Gabriela Hobbs MD | None | AbbVie, Inc. Bristol-Myers Squibb Company Cogent Incyte Corporation MorphoSys AG Novartis Pharmaceuticals Corporation Pfizer Inc. Pharmaessentia Pharmaxis Protagonist |
None | None | 01/10/2023 |
| Hagop Kantarjian MD | None | None | AbbVie, Inc. Amgen Inc. Astellas Pharma US, Inc. Ipsen Novartis Pharmaceuticals Corporation Pfizer Inc. Takeda Pharmaceuticals North America, Inc. |
None | 02/21/2023 |
| Lori Maness MD | None | None | None | None | 05/02/2023 |
| Leland Metheny MD | Adienne Pfizer Inc. |
Gamida Incyte Corporation Pfizer Inc./Hospira Inc. |
None | None | 03/21/2023 |
| Sanjay Mohan MD,MSCI | Incyte Corporation Karyopharm Therapeutics Taiho Pharmaceuticals Co., Ltd. |
None | None | None | 03/25/2023 |
| Joseph Moore MD | Pharmacyclics | None | None | None | 02/03/2023 |
| Vivian Oehler MD | Actuate/Courante Oncology Ascentage Astex Pharmaceuticals Bristol-Myers Squibb Company Pfizer Inc. |
Novartis Pharmaceuticals Corporation | None | None | 03/21/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 05/11/2023 |
| Keith Pratz MD | AbbVie, Inc. Astellas Pharma US, Inc. Takeda Pharmaceuticals North America, Inc. |
AbbVie, Inc. AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Roche Laboratories, Inc. Servier |
None | None | 03/09/2023 |
| Iskra Pusic MD,MSCI | GlaxoSmithKline Kadmon Pharmacyclics SYNDAX |
Incyte Corporation | None | None | 01/16/2023 |
| Michal Rose MD | None | None | None | None | 01/15/2023 |
| Neil Shah PhD,MD | Aerovate Therapeutics Bristol-Myers Squibb Company Taiho Pharmaceuticals Co., Ltd. |
Aerovate Therapeutics | None | None | 03/09/2023 |
| William Shomali MD | Blueprint Medicines Incyte Corporation |
Incyte Corporation | None | None | 03/05/2023 |
| B. Douglas Smith MD | Cellularity | Bristol-Myers Squibb Company CSL-Behring Novartis Pharmaceuticals Corporation Pfizer Inc. Servier |
None | None | 05/14/2023 |
| Michael Styler MD | Janssen Pharmaceutica Products, LP | None | None | None | 02/27/2023 |
| Hema Sundar PhD | None | None | None | None | 04/28/2023 |
| Bettyanne Sunderland OCN,RN,BSN | None | None | None | None | 01/27/2023 |
| Kendra Sweet MS,MD | AROG Incyte Corporation |
BerGenBio Bristol-Myers Squibb Company Jazz Pharmaceuticals Inc. Mablytics Novartis Pharmaceuticals Corporation |
Curio Science | None | 03/16/2023 |
| Moshe Talpaz MD | None | Bristol-Myers Squibb Company IMAGO Kyowa Kirin Novartis Pharmaceuticals Corporation Sierra Oncology Sumitomo |
None | None | 03/09/2023 |
| Tiffany Tanaka MD | None | None | CTI BioPharma Corp. Gilead Sciences, Inc. |
None | 05/01/2023 |
| Srinivas Tantravahi MBBS,MRCP | Karyopharm Therapeutics | AbbVie, Inc. Guidant Corporation Karyopharm Therapeutics Novartis Pharmaceuticals Corporation |
None | None | 02/27/2023 |
| James Thompson MS,MD | Bristol-Myers Squibb Company Novartis Pharmaceuticals Corporation |
None | None | None | 03/23/2023 |
| Steven Tsai MD,PhD | None | None | None | None | 04/19/2023 |
| Jennifer Vaughn MSPH,MD | None | None | Cogent Pharmaceuticals Ionis |
None | 03/22/2023 |
| Jeanna Welborn MD | None | None | None | None | 02/16/2023 |
| David Yang MD | Flambeau Diagnostics | None | None | None | 01/23/2023 |